Founded in 2018, Sphera Biotech focuses on highly innovative small and mid-cap companies in the global biotechnology sector. Sphera Biotech’s investments are based on comprehensive scientific research conducted by teams of scientists, doctors, and investment experts operating in Tel Aviv. The team of analysts is organized by therapeutic category, allowing deep insights and expertise into treatment modalities. The investment team’s research process seeks to use this enhanced perspective to detect disruptive technologies at an early stage.
We value your privacy
We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy
Customise Consent Preferences
We use cookies to help you navigate efficiently and perform certain functions. Manage each category below.
NecessaryAlways Active
Active
Functional
Social sharing, feedback, and third-party features.
Analytics
Metrics like visitors, bounce rate, traffic source, etc.